These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15243010)

  • 1. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder.
    Cox DJ; Humphrey JW; Merkel RL; Penberthy JK; Kovatchev B
    J Am Board Fam Pract; 2004; 17(4):235-9. PubMed ID: 15243010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Moore M; Burket R; Merkel RL; Mikami AY; Kovatchev B
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):1-10. PubMed ID: 18294083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.
    Cox DJ; Merkel RL; Penberthy JK; Kovatchev B; Hankin CS
    J Am Acad Child Adolesc Psychiatry; 2004 Mar; 43(3):269-75. PubMed ID: 15076259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
    J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.
    Verster JC; Roth T
    J Clin Psychopharmacol; 2014 Oct; 34(5):633-6. PubMed ID: 24978156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of methylphenidate on sustained attention among adolescents with attention-deficit hyperactivity disorder.
    Lufi D; Bassin-Savion S; Rubel L
    Neurocase; 2015; 21(6):802-8. PubMed ID: 25771849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial.
    Cox DJ; Merkel RL; Kovatchev B; Seward R
    J Nerv Ment Dis; 2000 Apr; 188(4):230-4. PubMed ID: 10790000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of stimulant and non-stimulant drug treatment on driving performance in patients with attention deficit hyperactivity disorder: a systematic review.
    Gobbo MA; Louzã MR
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1425-43. PubMed ID: 25044052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
    Su Y; Yang L; Stein MA; Cao Q; Wang Y
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day.
    Günther T; Kahraman-Lanzerath B; Knospe EL; Herpertz-Dahlmann B; Konrad K
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):131-8. PubMed ID: 22364402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified-release methylphenidate.
    Hautmann C; Rothenberger A; Döpfner M
    BMC Psychiatry; 2013 Sep; 13():219. PubMed ID: 24004962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD.
    Paton K; Hammond P; Barry E; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Bellgrove MA; Gill M; Johnson KA
    Child Neuropsychol; 2014; 20(3):303-18. PubMed ID: 23639119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder.
    Barkley RA; Murphy KR; O'Connell T; Connor DF
    J Safety Res; 2005; 36(2):121-31. PubMed ID: 15896352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder.
    Günther T; Herpertz-Dahlmann B; Konrad K
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):179-86. PubMed ID: 20578930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.